Biotech firm Propanc secures $100m for digital asset acquisition

Propanc Biopharma, a Nasdaq-listed biotech firm, has secured up to $100 million to bolster its digital asset strategy.

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Interview | TradFi doesn’t see the potential of stablecoins: Mega Matrix

Next Post

SUI Group partners with Bluefin to bring Wall Street to Sui

Related Posts